Thus, these analyses examine the effects of ERN/LRPT on relationships between apoB:LDL-C and apoB:non-HDL-C in T2DM patients, the majority of whom were taking a statin-based therapy. The gene discussed is APOB; the disease is type 2 diabetes mellitus.